Hematology/Oncology · Bethesda, MD
NPI
1033360946
Since 2008
Specialty
Hematology/Oncology
Code 390200000X
Group practices
1
Medicare group memberships
Hospitals
0
Hospital affiliations
8901 Wisconsin Ave, Gme Office, Bldg 10, Room 1006
Bethesda, MD, 20889
Phone (630) 935-7584
Groups this clinician bills Medicare through
Medicare paid
-
No Medicare services published
Medicare patients
-
Drug cost, 2024
$4.6M
553 prescriptions
Company payments
-
None reported
Medicare prescription drug claims, 2024
In 2024, the drug Jeffrey J Levine prescribed most often to Medicare patients was Tagrisso (Osimertinib Mesylate), with 152 prescriptions and refills. In total Jeffrey J Levine wrote 553 Medicare prescriptions that cost $4.6M.
| Drug |
|---|
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2022-02-11.
| Claims |
|---|
| 30-day fills |
|---|
| Patients |
|---|
| Cost |
|---|
| Tagrisso Osimertinib Mesylate | 152 | 152 | 19 | $2.6M |
| Prednisone Generic | 26 | 52 | Under 11 | $229 |
| Mekinist Trametinib Dimethyl Sulfoxide | 23 | 23 | Under 11 | $356K |
| Gabapentin Generic | 23 | 35 | Under 11 | $376 |
| Tafinlar Dabrafenib Mesylate | 23 | 23 | Under 11 | $328K |
| Abiraterone Acetate Generic | 19 | 27 | Under 11 | $5,264 |
| Lorbrena Lorlatinib | 18 | 18 | Under 11 | $418K |
| Everolimus Generic | 18 | 18 | Under 11 | $5,610 |
| Albuterol Sulfate Hfa Albuterol Sulfate | 17 | 17 | Under 11 | $276 |
| Prochlorperazine Maleate Generic | 13 | 13 | Under 11 | $188 |
| Erivedge Vismodegib | 13 | 13 | Under 11 | $189K |
| Anastrozole Generic | 13 | 39 | Under 11 | $367 |
| Xalkori Crizotinib | 12 | 12 | Under 11 | $139K |
| Dexamethasone Generic | 11 | 11 | Under 11 | $320 |
Brand drugs: 300 claims; generic drugs: 253 claims.
Money and other things of value reported by the companies
No payments from drug or medical device companies to Jeffrey J Levine were reported in the years we have.
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.